Osaic Holdings
BEAM icon

Osaic Holdings’s Beam Therapeutics BEAM Stock Holding History

Osaic Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$2.44K – 7410
2024
Q1 		$2.44K Hold
2
– – ﹤0.01% 6394
2023
Q4 		$1.72K Buy
+2
New +$50 ﹤0.01% 6585

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Osaic Holdings's BEAM Position: Q1 2026 in Review

Osaic Holdings reduced its Beam Therapeutics (BEAM) stake by 2.6% in Q1 2026, selling an estimated $4.11K and leaving 5,507 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #4483.

Osaic Holdings first reported a position in BEAM in Q2 2020 and has held it in 24 quarters since. The position peaked at $2.21M in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Osaic Holdings held 5,507 shares of Beam Therapeutics worth $131K as of Q1 2026.
  • Osaic Holdings sold 148 Beam Therapeutics shares in Q1 2026, an estimated $4.11K.
  • Beam Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4483 holding.
  • Osaic Holdings first reported a position in Beam Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Beam Therapeutics position peaked at $2.21M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.